Proposal to allow wider access to naloxone for use in emergencies
- Medicines and Healthcare products Regulatory Agency
- First published:
- 20 November 2013
- Last updated:
- 26 June 2015, see all updates
We are analysing your feedback
Visit this page again soon to download the outcome to this public feedback.
Detail of feedback received
We received a total of 122 responses by the closing date of the consultation. 118 were in support of the proposals contained in the consultation letter. The remainder did not object, they did not answer the question of support clearly.
Respondents came from a wide variety of patient-facing services and representative bodies. Those in contact with injecting drug users included:
- drug treatment service and NSP staff managers in the NHS and voluntary sector
- family members
- friends and carers
- hostel staff and managers
- trainers and researchers
Among those broader bodies supporting the proposals were:
- Guild of Healthcare Pharmacists, Pharmacy Voice and the Royal Pharmaceutical Society
- NHS England health and criminal justice reference group
- National Offender Management Service
- Royal College of Psychiatrists
- National Needle Exchange Forum
- Scottish Drugs Forum
This consultation ran from
The MHRA is asking for feedback on a proposal to allow wider access to naloxone for the purpose of saving life in an emergency.
PDF, 70.3KB, 9 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email firstname.lastname@example.org. Please tell us what format you need. It will help us if you say what assistive technology you use.
The MHRA is asking for feedback to a proposal to allow wider access to naloxone for the purpose of saving life in an emergency. This would be achieved by an amendment of the Human Use Regulations 2012. The proposal is aimed at reducing deaths from heroin overdoses. The consultation document has been jointly produced by the UK Health Departments and the MHRA.
Published: 20 November 2013
Updated: 26 June 2015
- Public feedback
- First published.